Team Member - BiopharmPK- IVIVC- PBPK

InvaGen Pharmaceuticals Inc; Maharashtra; On-site; INR 1,800,000 - 2,600,000; Full time

Job summary

InvaGen Pharmaceuticals Inc. seeks a senior PBPK/PBBM scientist to provide advanced modeling support across the drug development lifecycle.

You will build and apply PBPK/PBBM models to assess biopharmaceutics risks, guide formulation strategies, and prepare submission-ready documents for global regulators. Collaborating with Formulations R&D, Clinical R&D, Analytical/Formulations, and Regulatory Affairs, you will drive adoption of PBPK/PBBM methods, mentor team members, and contribute to

Qualifications

• Masters degree in Pharmaceutical Sciences or related field with 5–8 years of PBPK/PBBM experience.
• Hands-on expertise in biopharmaceutics, pharmacokinetics, bioequivalence, and regulatory submissions.
• Experience with biowaiver strategies and risk assessment in drug development.

Responsibilities

• Develop and apply PBPK/PBBM models to support drug development and regulatory submissions.
• Support regulatory strategies and global submissions, including justifications for biowaivers to optimize timelines.
• Promote adoption of PBPK/PBBM approaches across internal teams and external consultants.

Skills

PBPK/PBBM modeling

Biopharmaceutics

Pharmacokinetics

Bioequivalence

Regulatory submissions

Risk assessments

Education

Masters degree in Pharmaceutical Sciences

Job description

Job Description:

Division

Department

Sub Department 1

Job Purpose

Provide advanced Physiologically Based Pharmacokinetic (PBPK) and Physiologically Based Biopharmaceutics Modeling (PBBM) support across the drug development lifecycle, contributing to biopharmaceutics risk assessment, formulation strategies, and regulatory submissions for global markets.

Key Accountabilities (1/6)

Develop and apply PBPK/PBBM models to support drug development.

• • Build, verify, and utilize PBPK/PBBM models to assess biopharmaceutics risks, perform virtual bioequivalence (BE) studies, and guide formulation development Conduct sensitivity and uncertainty analyses, perform in vitro-in vivo correlation (IVIVC) and in vitro-in vivo relationship (IVIVR) studies, and generate submission-ready documents to streamline regulatory processes

Key Accountabilities (2/6)

Support regulatory strategies and global submissions

• • Collaborate with cross-functional teams to apply PBPK/PBBM approaches in preparing robust regulatory submissions, aligned with global requirements such as USFDA and EMA guidelines Justify biowaivers effectively to minimize the need for costly BE studies, thereby optimizing timelines and resource utilization

Key Accountabilities (3/6)

Promote adoption of PBPK/PBBM approaches.

• • Build awareness and drive implementation of PBPK/PBBM frameworks by partnering with internal stakeholders and collaborating with external technical consultants Provide solutions for project challenges and ensure seamless integration of these techniques into development workflows

Key Accountabilities (4/6)

Contribute to knowledge building and capability enhancement.

• • Mentor team members on modeling and simulation techniques, continuously update technical knowledge through literature reviews, and contribute to scientific publications Engage in internal training programs to enhance the organizations modeling capabilities and readiness for future challenges

Key Accountabilities (5/6)

Ensure cross-functional collaboration for project success.

• • Coordinate with internal teams such as Formulations R&D, Clinical R&D, Analytical/Formulations, and Regulatory Affairs to align strategies and resolve development challenges Liaise with external consultants to tackle technical complexities, ensuring project deliverables are achieved without compromise

Key Accountabilities (6/6)

Major Challenges

• • Driving alignment and decision-making in decentralized cross-functional teams
• • Ensuring adherence to regulatory expectations for PBPK/PBBM submissions across diverse geographies
• • Balancing innovation and cost optimization by minimizing reliance on BE studies through biowaiver filings

Key Interactions (1/2)

Internal

• • Formulations R&D team for project execution and updates
• • , Clinical R&D for aligning on clinical study design and status
• • , Analytical/Formulations team for analytical data support and insights• , Regulatory department for submission preparation and query resolution

Key Interactions (2/2)

External

• • Technical consultants for inputs, troubleshooting, and problem resolution
• • , Global regulatory bodies during submission reviews and queries

Dimensions (1/2)

• • Headcount: 3000
• • Team Size (Direct): 0
• • Team Size (Indirect): 0
• • Number of PBPK/PBBM Models Developed: 15 annually
• • Regulatory Submissions Supported: 10 annually
• • Adoption of PBPK/PBBM Approaches: 5 projects annually
• • Biowaiver Filings Approved: 12 annually
• • Cross-Functional Collaboration Metrics: 90% adherence

Dimensions (2/2)

Key Decisions (1/2)

Decisions

• • Finalize biorelevant in‑vitro methods and formulation strategies
• • Determine the technical readiness of documents related to dossier submissions
• • Approve virtual BE simulation outputs and biowaiver justifications

Key Decisions (2/2)

Recommendations

• • Propose budget-related approvals for software purchases and consultant hiring
• • Recommend formulations for bioequivalence studies to HOD and cross-functional teams

Education Qualification

Skills & Knowledge: Masters degree in Pharmaceutical Sciences, Pharmacokinetics, or related fields (advanced degrees preferred). Relevant Experience: 5-8 years in PBPK/PBBM modeling, biopharmaceutics, pharmacokinetics, bioequivalence, formulation bridging, and regulatory submissions. Demonstrated expertise in biowaiver strategies and risk assessments.

Relevant Work Experience

Requirements: